AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $266B; returns 1 day -0.6%, 1 week +3.7%, 1 year +4.6%.

AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription medicines. Its revenue generation is heavily diversified across several key therapeutic areas. In fiscal year 2024, the company reported total revenue of $54.073 billion, with strong growth across all major segments.

Groups AZN belongs to

• Dividend Payers
• Healthcare
• 25-Year Dividend Payers
• Biopharmaceutical
• Recent Reverse Splits
• Pharmaceuticals
• United Kingdom Companies
• Biotechnology
• Oncology
• Life Sciences
• Breast Cancer Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Rare Diseases
• Cardiovascular Therapies
• Antibody-Drug Conjugates
• Immunotherapy
• Autoimmune Diseases
• Metabolic Disorders

AZN financial model: income statement, cash flow and balance sheet